top of page
Blog: Blog2
Search


Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Each edition highlights the decisions that move GPCR projects forward—from pharmacology essentials to ligand binding site strategies, bench-ready tools, and industry momentum shaping GPCR pipelines. Read fast, apply faster, and stay ahead in GPCR drug discovery with evidence-based insights—no hype, just strategies you can use.

Dr. GPCR News
Oct 25 min read


How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Early signals can mislead. This week’s Dr. GPCR Weekly shows how to call Mechanism of Action with model-first rigor—distinguishing orthosteric vs. allosteric, designing assays that reveal mechanism, and unlocking SAR. Plus: Novo’s \$550M obesity/diabetes push, Rhythm’s sNDA, key events, and confocal imaging that respects function. Upgrade to Premium for the full digest.

Dr. GPCR News
Sep 184 min read
bottom of page